Aurora Spine Announces New Chief Financial Officer and Chief Operations Officer!
Aurora Spine Corporation (TSXV: ASG) today announced the appointment Eric Fronk as their Chief Financial Officer (CFO), and Kenneth Gross as their new Chief Operating Officer (COO).
Mr. Fronk will help guide and oversee the company's continued market leadership and financial growth. He brings more than 21 years of experience to Aurora, including CFO of Digital Interactive Systems, a manufacturing and distribution services company.
Prior to joining Aurora Spine, Mr. Fronk was part of the team that prepared Alphatec Spine Inc. for its IPO – occurring in 2006. From 2002-2005, he was part of the team that led the restructuring and turnaround of Peregrine Systems Corp, a previously bankrupt software development company.
Mr. Fronk began his career with Ernst and Young and PricewaterhouseCoopers, where he spent eight years working primarily in high-tech and pharmaceutical industries. Mr. Fronk earned a Bachelor of Science in Accounting from Brigham Young University and received a Master in Business Administration from the University of Southern California.
As former CFO of Aurora Spine, Mr. Gross will be taking over the position of COO. In this role he will be responsible for the alignment and prioritization of company investments, product manufacturing, and ensuring operational excellence across the Company making it efficient and effective.
"2013 marks a significant turning point for Aurora Spine," said Trent J. Northcutt, Aurora Spine's Chief Executive Officer. "With our successful IPO, product manufacturing and the pending US launch, we knew we needed the right leaders to take us to the next level of our business' evolution. Between Eric's public experience in financial management, and Ken's strategic operation vision, we have created the right infrastructure to support our progression into the industry leader of advanced minimally invasive spinal technology."
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the growth potential of the Aurora Spine"s products. Aurora Spine cautions investors of Aurora Spine"s securities about important factors that could cause Aurora Spine"s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
For more information, please contact:
Aurora Spine Corporation
President and Chief Executive Officer
Chief Financial Officer